Form 8-K - Current report:
SEC Accession No. 0001558370-21-012772
Filing Date
2021-09-27
Accepted
2021-09-27 16:20:30
Documents
13
Period of Report
2021-09-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20210927x8k.htm   iXBRL 8-K 36319
2 EX-99.1 aytu-20210927xex99d1.htm EX-99.1 213277
  Complete submission text file 0001558370-21-012772.txt   388489

Data Files

Seq Description Document Type Size
3 EX-101.SCH aytu-20210927.xsd EX-101.SCH 3031
4 EX-101.LAB aytu-20210927_lab.xml EX-101.LAB 16077
5 EX-101.PRE aytu-20210927_pre.xml EX-101.PRE 10208
6 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20210927x8k_htm.xml XML 4860
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 211281959
SIC: 2834 Pharmaceutical Preparations